ARQT:NASDAQ, Arcutis Biotherapeutics, Inc.

ARQT stock overview

Arcutis Biotherapeutics, Inc. (ARQT:NASDAQ) closed at $26.36 on November 20, 2026, down 2.98% on the day. The stock trades 24.3% below its 52-week high of $34.80 and 36.6% above its 52-week low of $19.30. Over the past year, it lost 10.6%. Arcutis Biotherapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$26.36
Day change
-2.98%
Volume
1,290,015
Average volume
2,594,581
Market cap
3B+
52-week range
$19.30 – $34.80
50-day average
$27.81
200-day average
$25.41

Price action over the past year

In 252 trading sessions since November 20, 2025, ARQT closed higher on 125 days (50%). Its best day was September 16, 2026 (+11.19%) and its worst was November 5, 2026 (-20.70%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

ARQT news

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. The company targets immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Similar stocks

Find more stocks like ARQT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.